About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

Heaviest burden born by regions with high sociodemographic index, apart from Japan, which had declining trends.

Similar increases observed for higher-order births; increase in mean age at first birth seen in all racial and ethnic groups.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Steqeyma is now supplied as a 45mg/0.5mL solution in a single-dose vial for subcutaneous injection, allowing for weight-based dosing for pediatric patients under 60kg.

Pediatricians should provide their patients with their contraceptive of choice, if no medical contraindications exist.

The approval was based on two phase 1 crossover studies, which compared zanubrutinib tablets with the capsule formulation in healthy adult participants.

A second case of acute liver failure resulting in death has been reported in nonambulatory DMD patients treated with Elevidys.